A large number of studies have shown that activation of adenosine monophosphate-activated protein kinase (AMPK) and suppression of the activity of protein tyrosine phosphatase 1B (PTP1B) are effective treatments for T2DM. This evidence concerns the gene PTPN1 and type 2 diabetes mellitus.